Farmacon Global

Farmacon Global Speeds Up Patient Recruitment - mailchi.mp/25f4fb03dc04/f…

100% Excellent Score from DIA in Present Follow-up Survey - mailchi.mp/2d71bf229f0b/f…

New Farmacon Academy’s Clinical Research Training: ‘Avant-garde’ - mailchi.mp/5241ca0872f0/f…

Calls to Action in Rare Disease Realm. - mailchi.mp/d1db0469829e/f…

Experts Tackling Rare Disease Issues in Emerging Markets Next Thursday - mailchi.mp/88b6060010c6/f…

Farmacon Global Newsbrief - Discussing Pathways to Solutions in Rare Disease - mailchi.mp/72bbfbef0743/f…

Farmacon Global Newsbrief - UC San Diego Brings Value to Rare Disease Discussion - mailchi.mp/0aa38682a0b4/f…

Farmacon Global Newsbrief - Mirum Pharmaceuticals - mailchi.mp/40413e38ebca/f…

Farmacon Global Newsbrief - Americas Health Foundation - mailchi.mp/f70e8249c31b/f…

Farmacon Global Newsbrief - Rare Diem 2022 - mailchi.mp/78f998b48221/f…

Farmacon Global Newsbrief - DIA 2022 - mailchi.mp/244e1899c4e8/f…

Farmacon Global Newsbrief - DIA 2022 - mailchi.mp/e8df886f6324/f…

Farmacon Global Newsbrief - May 11th, 2022 - mailchi.mp/f6b8d2d431ed/f…

Farmacon Global Newsbrief - April 27rd, 2022 - mailchi.mp/6d90af79cac7/f…

Farmacon Global Newsbrief - April 27rd, 2022 - mailchi.mp/a70b864edb2d/f…

Farmacon Global Newsbrief - March 10th, 2022 - mailchi.mp/3badf835b7ae/f…

Farmacon Global Newsbrief - February 24th, 2022 - mailchi.mp/3d51741596d8/f…

Farmacon Global Newsbrief - February 17, 2022 - mailchi.mp/12d686b77e64/f…

Farmacon Global Newsbrief - February 17, 2022 - mailchi.mp/939929eb2558/f…

Farmacon Global Newsbrief - January 27, 2022 - mailchi.mp/639d5e121ac3/f…